Cytosorbents (CTSO) Net Cash Flow (2010 - 2026)
Cytosorbents' (CTSO) quarterly Net Cash Flow came in at -$1.2 million in Q1 2026, down 136.41% YoY from $3.3 million in Q1 2025, and up 54.21% on a QoQ basis from -$2.6 million in Q4 2025.
Cytosorbents (CTSO) Net Cash Flow (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Net Cash Flow data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Net Cash Flow fell 136.41% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.0 million (down 359.99% YoY) and the FY2025 annual result came in at -$3.5 million, up 39.59% from the prior year.
- Net Cash Flow improved to -$1.2 million in Q1 2026, from -$2.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $5.7 million in Q4 2023 to a low of -$12.7 million in Q2 2022.
- A 5-year average of -$2.8 million and a median of -$2.6 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 340.15% — and 2023, when it jumped 1137.17%.
- Tracing CTSO's Net Cash Flow over 5 years: stood at -$546406.0 in 2022, then jumped by 1137.17% to $5.7 million in 2023, then tumbled by 140.55% to -$2.3 million in 2024, then dropped by 14.8% to -$2.6 million in 2025, then surged by 54.21% to -$1.2 million in 2026.
- The last three Net Cash Flow figures came in at -$1.2 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -576,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -576,000.00 |
| Jun 30, 2026 | -576,000.00 |
| Mar 31, 2026 | -1.21 Mn |
| Mar 31, 2026 | -1.21 Mn |
| Dec 31, 2025 | -2.64 Mn |
| Dec 31, 2025 | -2.64 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | -1.64 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | 4.92 Mn |
| Jun 30, 2024 | 4.92 Mn |
| Mar 31, 2024 | -5.53 Mn |
| Mar 31, 2024 | -5.53 Mn |